• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    Concentrated Tylenol Infants' Drops Plus Cold & Cough is shown at a home in Palo Alto, Calif., Thursday, Oct. 11, 2007.
    Healthcare

    Children’s fever and pain relieving meds are in short supply — here’s why

    Abigail Adcox -
    December 20, 2022 10:07 am
    0
    CVS and Walgreens to limit purchases of children’s pain and fever medications
    Business

    CVS and Walgreens to limit purchases of children’s pain and fever medications

    Abigail Adcox -
    December 19, 2022 10:40 pm
    0
    Kelleigh Eastman, a special projects director with the Baltimore City Health Department, reaches for a package of Narcan nasal spray in Baltimore.

    Here’s how Americans can get Naloxone to prevent opioid poisoning, save lives

    Washington Examiner -
    December 12, 2022 1:22 pm
    0
    The company will provide the nasal spray Narcan without a co-pay. (AP Photo/John Minchillo)
    Politics

    FDA to fast-track review of application to allow NARCAN to be sold over the counter

    Washington Examiner -
    December 7, 2022 1:29 pm
    0
    Republicans need a healthcare agenda
    News

    Republicans need a healthcare agenda

    Ann Marie Buerkle -
    December 5, 2022 12:00 am
    0
    Anticipation and skepticism surround Alzheimer’s drug on fast track for approval
    Healthcare

    Anticipation and skepticism surround Alzheimer’s drug on fast track for approval

    Abigail Adcox -
    November 28, 2022 9:00 pm
    0
    FDA approves first drug to delay onset of Type 1 diabetes
    Healthcare

    FDA approves first drug to delay onset of Type 1 diabetes

    Misty Severi -
    November 18, 2022 9:46 pm
    0
    Adderall shortage fueled by sharp rise in ADHD diagnoses
    News

    Adderall shortage fueled by sharp rise in ADHD diagnoses

    Abigail Adcox -
    November 15, 2022 4:29 pm
    0
    Experimental Alzheimer’s drug fails to slow cognitive decline in clinical trials
    News

    Experimental Alzheimer’s drug fails to slow cognitive decline in clinical trials

    Abigail Adcox -
    November 14, 2022 4:36 pm
    0
    Nearly 90% of community pharmacies report issues stocking Adderall
    News

    Nearly 90% of community pharmacies report issues stocking Adderall

    Abigail Adcox -
    November 3, 2022 7:01 pm
    0
    1...313233...157Page 32 of 157
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.